Immunologic changes point to potential for clinical investigation...
Immunologic changes observed in an early study of patients with metastatic renal cell carcinoma (MRCC) raised the possibility for a...
Protein identified as potential druggable target for...
A protein known as arginine methyltransferase 1 (PRMT1) may be a potential therapeutic target for pancreatic ductal adenocarcinoma...
Minority colorectal cancer patients report higher burden of...
A study of racial disparities in health-related quality of life of colorectal cancer patients revealed among several findings, that...
Study provides path for new immunotherapy approaches to prostate...
Prostate cancer, notoriously resistant to immunotherapy due to its immunologically cool nature, triggers two pathways to chill an...
Jerry Jeff Walker to headline April 29 Polo on the Prairie...
The 31st annual Polo on the Prairie, a U.S. Polo Association-sanctioned event benefiting cancer research and patient care programs at...
MD Anderson expert to lead Dallas panels on Alzheimer’s...
The University of Texas MD Anderson Cancer Center brings Jim Ray, Ph.D., head of Neuroscience, to Dallas on Thursday, April 20, to...
Marshall E. Hicks named interim president of UT MD Anderson Cancer...
University of Texas System Chancellor William H. McRaven announced today the appointment of Marshall E. Hicks, M.D., as interim...
Advanced form of proton therapy shows promise for treating...
An advanced form of image-guided radiation therapy, known as intensity modulated proton therapy (IMPT), has shown early promise for...
MD Anderson celebrates the mission of Kick Butts Day
As an institution devoted to eliminating cancer, The University of Texas MD Anderson Cancer Center proudly supports the mission of...
Change in Leadership at MD Anderson
Ronald A. DePinho M.D., president of The University of Texas MD Anderson Cancer Center, has submitted a letter to Chancellor William...
Statement from The University of Texas System Chancellor William...
When Dr. Ron DePinho was named president of The University of Texas MD Anderson Cancer Center by the Board of Regents in 2011, ...
Functional brain training alleviates chemotherapy-induced...
A type of functional brain training known as neurofeedback shows promise in reducing symptoms of chemotherapy-induced nerve damage, or...
MD Anderson to provide skin cancer screenings, cancer...
Cancer prevention specialists from The University of Texas MD Anderson Cancer Center will provide skin cancer screenings free to the...
Monoclonal antibody drug superior to chemotherapy for...
A Phase III clinical trial involving 101 centers in 21 countries revealed the monoclonal antibody blinatumomab to be more effective...
Absent tumor-suppressors allow melanoma to thwart...
It’s what’s missing in the tumor genome, not what’s mutated, that thwarts treatment of metastatic melanoma with immune checkpoint...
MD Anderson study ties protein ‘reader’ ENL to common...
Anyone who uses an employee badge to enter a building may understand how a protein called ENL opens new possibilities for treating...